Clinical Trials
2 trialsNCT05498389 2023-06-01
EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer
Shanghai EpimAb Biotherapeutics Co., Ltd.
Phase 1/2 Unknown
NCT05284994 2022-03-17
TQ-B3525 Tablets Combined With Osimertinib Mesylate Tablets in the Treatment of Advanced Non-Small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2 Unknown